FIT PATIENTS

Clinical trials for FIT PATIENTS explained in plain language.

Never miss a new study

Get alerted when new FIT PATIENTS trials appear

Sign up with your email to follow new studies for FIT PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Chemo-Free hope: new combo aims to outsmart CLL

Disease control Completed

This phase 2 trial tested a combination of two targeted drugs, venetoclax and ibrutinib, against standard chemotherapy (FCR) in 120 fit patients with intermediate-risk chronic lymphocytic leukemia (CLL). The goal was to see if the drug combo could achieve deep remission with a fi…

Matched conditions: FIT PATIENTS

Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

FIT PATIENTS

Get alerted when new FIT PATIENTS trials appear

Chemo-Free hope: new combo aims to outsmart CLL